3-6-2018A new CDC analysis suggests that only a small percentage of Americans who could benefit from pre-exposure prophylaxis (PrEP), a daily pill for HIV prevention, h…
3-6-2018Advances in HIV research are being shared this week at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, and HIV.gov is here sh…
3-5-2018A one-month antibiotic regimen to prevent active tuberculosis (TB) disease was at least as safe and effective as the standard nine-month therapy for people livi…
3-5-2018A woman’s risk of acquiring HIV through sex with a male partner living with HIV increases during pregnancy and is highest during the postpartum period, ne…
3-1-2018The 2018 Conference on Retroviruses and Opportunistic Infections (CROI) takes place next week in Boston, and HIV.gov will be there to share news about the HIV r…
2-16-2017As the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) wrapped up in Seattle, we spoke again with Dr. Carl Dieffenbach about some of the sc…
2-15-2017New scientific findings from two separate domains were among the key highlights shared during the second day of the 2017 Conference on Retroviruses and Opportun…
2-14-2017This week, we’re at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle sharing news and information about some of the importa…
2-14-2017Decline signals HIV prevention and treatment efforts in the U.S. are paying off, but not all communities are seeing the same progress.The number of annual HIV i…
2-13-2017As Dr. Richard Wolitski, Director of the Office of HIV/AIDS and Infectious Disease Policy, shared in a post to learn more. We encourage everyone to watch, comme…
